HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Phthalates comment period

This article was originally published in The Rose Sheet

Executive Summary

California Office of Environmental Health Hazard Assessment extends public comment period to Aug. 26 for butyl benzyl phthalate, di-n-butyl phthalate, di-n-hexyl phthalate and di-isodecyl phthalate, which are under consideration for possible listing as carcinogens under Proposition 65, agency announces. Phthalates also will be addressed by the California Senate next month when it considers AB 2012, which seeks to ban the manufacture and distribution of personal care products formulated with the chemicals. Bill passed the state's Senate Health and Human Services Committee June 30 (1"The Rose Sheet" July 5, 2004, p. 5)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel